Alembic Pharma (Oral Solids ==> Injectables, Onco, Derma, Opthalmic)

Most of the Indian Parma serving US are having pricing pressure for the past 5+ years. A few years back, the reason given was buyer consolidation and bargaining power of them. Is it the only reason for current pricing pressure or any other reasons?

Many Indian Parma companies are adding capacity at break-neck speed. Is the industry overspending on capacity?

1 Like